{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004239691292160.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3892/mco.2014.259"}},{"identifier":{"@type":"URI","@value":"https://spandidos-publications.com/10.3892/mco.2014.259/download"}},{"identifier":{"@type":"PMID","@value":"24772306"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis"}],"description":[{"notation":[{"@value":"Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The aim of this study was to evaluate whether there are differences in the clinical characteristics and survival between patients with advanced HCC with extrahepatic metastasis who received and those who did not receive previous treatment. Between April, 1998 and April, 2012, a total of 419 HCC patients with extrahepatic metastasis (81 previously untreated and 338 previously treated) were enrolled in this study. The differences in the clinical characteristics, including metastatic sites, were compared between the two groups. In addition, the prognostic predictors among all the patients and among the 81 previously untreated patients were analyzed. The distribution of the major metastatic sites was similar in the two groups; the most frequent site of extrahepatic metastasis was the lungs, followed by the bones, lymph nodes and adrenal glands. The median survival time (MST) among the 419 patients was 6.8 months. The 1-, 2-, 3- and 5-year survival rates were 31.6, 15.3, 9.5 and 2.3%, respectively. No significant differences in survival were observed between patients who received and those who did not receive previous treatment. The multivariate analysis revealed that the Child-Pugh classification, white blood cell count, neutrophil-lymphocyte ratio (NLR) and primary tumor stage were independent predictors of survival for all the patients and for the 81 previously untreated patients. Differences in the clinical characteristics of patients with advanced HCC with extrahepatic metastasis were identified between patients who received and those who did not receive previous treatment. Furthermore, intrahepatic tumor status, Child-Pugh classification, white blood cell count and NLR were demonstrated to be independent predictors of survival in HCC patients with extrahepatic metastasis."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004239691292288","@type":"Researcher","foaf:name":[{"@value":"HAJIME AINO"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292163","@type":"Researcher","foaf:name":[{"@value":"SHUJI SUMIE"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292162","@type":"Researcher","foaf:name":[{"@value":"TAKASHI NIIZEKI"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292290","@type":"Researcher","foaf:name":[{"@value":"RYOKO KUROMATSU"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292426","@type":"Researcher","foaf:name":[{"@value":"NOBUYOSHI TAJIRI"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292422","@type":"Researcher","foaf:name":[{"@value":"MASAHITO NAKANO"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292297","@type":"Researcher","foaf:name":[{"@value":"MANABU SATANI"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292299","@type":"Researcher","foaf:name":[{"@value":"SHINGO YAMADA"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292304","@type":"Researcher","foaf:name":[{"@value":"SHUSUKE OKAMURA"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292307","@type":"Researcher","foaf:name":[{"@value":"SHIGEO SHIMOSE"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292294","@type":"Researcher","foaf:name":[{"@value":"HIROAKI SUMIE"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691292170","@type":"Researcher","foaf:name":[{"@value":"TAKUJI TORIMURA"}]},{"@id":"https://cir.nii.ac.jp/crid/1420282801193494144","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10162398"},{"@type":"NRID","@value":"1000010162398"},{"@type":"CINII_AUTHOR_ID","@value":"DA16142729"},{"@type":"URI","@value":"https://ci.nii.ac.jp/author/DA16142729#entity"},{"@type":"URI","@value":"https://viaf.org/viaf/NII%7CDA16142729"},{"@type":"NRID","@value":"9000022163939"},{"@type":"NRID","@value":"9000256570828"}],"foaf:name":[{"@value":"MICHIO SATA"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"20499450"},{"@type":"EISSN","@value":"20499469"}],"prism:publicationName":[{"@value":"Molecular and Clinical Oncology"}],"dc:publisher":[{"@value":"Spandidos Publications"}],"prism:publicationDate":"2014-02-14","prism:volume":"2","prism:number":"3","prism:startingPage":"393","prism:endingPage":"398"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://spandidos-publications.com/10.3892/mco.2014.259/download"}],"createdAt":"2014-02-14","modifiedAt":"2024-05-24","project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782259213184","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25461017"},{"@type":"JGN","@value":"JP25461017"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25461017/"}],"notation":[{"@language":"ja","@value":"非B非C肝がんの新規危険因子同定：GWASとデータマイニングによる網羅的解析"},{"@language":"en","@value":"Identification of new risk factor for nonB, nonC hepatocellular carcinoma: Global analysis using GWAS and data-mining analysis"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050015719934236928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Image-Guided Ablation Therapies for Extrahepatic Metastases from Hepatocellular Carcinoma: A Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002214520391296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatocellular carcinoma with extrahepatic metastasis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002215326460160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144858673792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390564461312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292618539654016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Preoperative Neutrophil‐to‐Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619782053248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620510738432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Surgical treatment of hepatocellular carcinoma: Similar long-term results despite geographic variations"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165242881280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinicopathologic Features and Risk Factors for Extrahepatic Recurrences of Hepatocellular Carcinoma After Curative Resection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168659995008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567179924769024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093667010432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical features of hepatocellular carcinoma with extrahepatic metastases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093847415296","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580229803106688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707379633152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045141673088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046054301440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519592497280","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519748800384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Randomized controlled trial of screening for hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520625804416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B Virus Infection Predicts Extrahepatic Metastasis After Hepatic Resection in Patients With Large Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699993496828160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Sorafenib in Advanced Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994176627712","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994544913152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699996249115648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469422959744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470665553408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470714636544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470970578432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Systemic therapy for advanced hepatocellular carcinoma: a review"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945823965440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Extrahepatic Metastases of Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420232617088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420804757760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical Cure"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895203427072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Neutrophil‐to‐lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895732586240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370747762176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844558099712","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Early and Late Recurrence After Liver Resection for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845514738944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Hepatocellular Carcinoma: An Update Δσ"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318212684544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319823555712","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320668330112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269645167232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer CXC chemokine networks and tumour angiogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270919910144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Independent Factors and Predictive Score for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233271103800192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3892/mco.2014.259"},{"@type":"KAKEN","@value":"PRODUCT-15078043"},{"@type":"OPENAIRE","@value":"doi_dedup___::ec6dd556b91c5d1df8b8c77178ed696d"},{"@type":"CROSSREF","@value":"10.3390/ijms241813715_references_DOI_57CkLAY5uxp1nud287BqxouEr5Q"},{"@type":"CROSSREF","@value":"10.3390/cancers15143665_references_DOI_57CkLAY5uxp1nud287BqxouEr5Q"},{"@type":"CROSSREF","@value":"10.1002/cam4.548_references_DOI_57CkLAY5uxp1nud287BqxouEr5Q"},{"@type":"CROSSREF","@value":"10.3390/cancers14194873_references_DOI_57CkLAY5uxp1nud287BqxouEr5Q"},{"@type":"CROSSREF","@value":"10.3390/cancers13040646_references_DOI_57CkLAY5uxp1nud287BqxouEr5Q"},{"@type":"CROSSREF","@value":"10.3350/cmh.2022.0391_references_DOI_57CkLAY5uxp1nud287BqxouEr5Q"}]}